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Introduction
Alkaline phosphatases (ALP) are a group of cell membrane
metalloenzymes that catalyze the hydrolysis of phosphate
esters in an alkaline environment, generating an organic radical
and inorganic phosphate (1). ALP is expressed mainly in bone,
liver, intestines, proximal convoluted tubules of the kidney, and
in the placenta. ALP released from these tissues constitutes the
total amount measured in the blood. Total ALP activity changes
with age and bone fraction, varying from 77% to 89% in 
children and from 58% to 67% in adults (3,4,5).  In contrast to
ALP isoenzymes, total serum ALP is widely used in routine 
biochemical tests and can be performed in almost all 
laboratories. Traditionally, total serum ALP activity has been
used as a biochemical marker for bone formation to assess
osteoblastic activity in primary hyperparathyroidism, rickets,
osteomalacia and Paget’s disease. Since ALP is a marker for
osteoblastic activity, growing children have higher levels than
fully grown individuals. Highest levels of ALP are detected 
during the rapid growth phases of childhood such as infancy and
puberty  (2,6,7,8). While it is known that reference values of
serum ALP are highly dependent on age and sex in childhood,
most commercial assay kits used in hospital laboratories provide
reference values for only adults and no specific references are
given for pediatric ages. Additionally, the colorimetric method
using p-nitrophenyl phosphate as substrate is the method used
by most clinical laboratories, but the buffer varies between
assays. 2-amino-2-methyl-1-propanol (AMP) is the buffer 
recommended by both the American Association for Clinical
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Chemistry (IFCC) (10); this buffer is also used in the method
described by Bretaudiere et al (11). On the other hand,
diethanolamine (DEA) is recommended by the Scandinavian
Society for Clinical Chemistry (SSCC) (12). Higher values were
obtained with the SSCC method (12), owing to the increased
sensitivity resulting from the use of DEA buffer. The lower 
values with the AACC/IFCC method (9,10) can be attributed to
a lower concentration determined with the AMP buffer.
Consequently, there are great variations in serum ALP levels
assayed in different laboratories and in the interpretation of the
results. Therefore, it is necessary to state the buffer used in 
the assay when reporting the ALP levels. This is particularly
important for the pediatric age group, in which the upper limit
of reference ranges may show an almost twofold variation.
In this study, we aimed to establish pediatric age- and 
sex-specific reference ranges for serum total ALP by the 
colorimetric method using p-nitrophenyl phosphate as 
substrate and diethanolamine as buffer and run by
Roche/Hitachi 917/MOD system. Additionally, we compared
the ALP z-scores of patients with different types of rickets by
using these reference ranges.
Methods
Sample Selection
We studied 1922 children aged 0 to 18 years who 
presented to the outpatient clinic for routine check-ups or 
for minor conditions requiring analysis of blood samples for
diagnosis. Children who showed clinical signs of any acute or
chronic illnesses affecting serum ALP levels were not included
in the study. Children and adolescents under treatment with
corticosteroids or anticonvulsants, those with neuromuscular
disorders or movement impairment, and those with genetic
syndromes or major congenital malformations were also
excluded. Additionally, serum parathormone (PTH) levels were
measured in children with ALP levels in the higher quartile
according to their age groups and the children with high PTH
levels were excluded from the study. 
The Ethics Committee of the Medical Faculty at the
Marmara University approved the study. Informed consent was
obtained from the parents of each child and from the child if
older than 16 years of age. The study was performed between
March 2003 and April 2006.
1741 children (904 girls and 837 boys) were included in the
final analysis after excluding subjects who were found to have
clinical or laboratory evidence of conditions, which might affect
the serum ALP levels. The age- and sex-specific reference
ranges for serum ALP levels were constructed from the data of
these 1741 children.  
Additionally, serum ALP levels of 77 different samples from
53 patients with active rickets were analyzed to determine the
ALP z-scores in different types of rickets and validate the 
constructed reference data. This group included 39 samples
from 38 children with nutritional rickets (NR) (27 males and 11
females), 19 samples from 7 (3 males, 4 females) with vitamin
D-dependent rickets (VDDR) and 19 samples from 8 (3 males,
5 females) with hypophosphatemic rickets (HR). 
Serum Analyses
Blood samples were drawn from an antecubital vein
between 08.00-13.00 hours and centrifuged thereafter. 
Blood samples were transferred to the central laboratory for
determination of ALP levels on the same day. Colorimetric
assay with a standardized method using p-nitrophenyl 
phosphate as substrate and diethanolamine as buffer was run
by Roche/Hitachi 917/MOD system. Detection limits of the
assay were 5 to 2 000 U/L and higher activities were re-run after
dilution.  The intra-assay coefficient of variation (CV) was 0.5%,
whereas the interassay CV was 2.2%.
Statistics
Results were presented as the mean and standard 
deviation (SD) values in 11 different age groups as shown in
Table 1.  Square root (SQR) transformation was used in 
the calculations since this transformation gave the best 
approximation to a normal distribution of the data. 
ALP z-score calculations were performed according to the
following formula:
z-score = (SQR of ALP value- mean of SQR ALP values for
the age group ) / SD of  SQR  ALP values for the age group
Statistical analyses were performed using Jandel SigmaStat
version 2.0. The unpaired t-test was used to compare ALP 
levels between girls and boys in different age groups. Kruskal-
Wallis one-way analysis of variance by ranks was used to 
compare ALP z-scores, PTH, calcium and phosphate leves
between the different types of rickets.  
Results
Serum ALP levels were highest in the first 6 months of life,
decreased to relatively steady levels thereafter and started to
increase again after age  9 years  (Figure 1). The pubertal peak
levels were not as high as the levels detected in the first 6
months of life.  ALP levels (+2SD) exceeding 900 U/L were
observed in two age groups in girls, namely 0-6 months and 
12-13 years. In boys, these high levels were observed in six age
groups, namely 0-6 months, 6-12 months, 1 year , 10-11 years,
12-13 years and 14-15 years (Table 1). Serum ALP levels 
were similar in boys and girls until age 10 years, but higher ALP
levels were noted at ages 10-11 years in girls (median values
were 572 and 525, respectively; p= 0.02) and in three age
groups, namely 12-13, 14-15 and 16-17 years in boys (median
values were 630 U/L, 518 U/L, 587 U/L, 251 U/L, 369U/L and
167 U/L, respectively; p<0.001). ALP levels start to decline after
12 years of age in girls and after 14 years of age in boys, with
upper ranges approaching the upper ranges of adults (240 U/L
for females, 270 U/L for males) in girls (293 U/L), but not in boys
(430 U/L) until they reach the ages of 16 to 18 years.  
Serum ALP Levels in Children with Rickets
The serum ALP levels from patients with NR prior to 
treatment were analyzed according to normative data obtained
in the study. Additionally, repeated measurements were 
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Alkaline Phosphatase in Ricketsperformed in the groups of VDDR and HR before treatment as
well as after the start of treatment if they continued to have
signs of active rickets related to compliance or other problems
at follow-up.  A total of 39 samples from 38 cases with NR, 
19 samples from 7 cases with VDDR, and 20 samples from 
8 cases with HR were obtained for final analysis. The 
biochemical data of patients with rickets are presented in 
Table 2. Serum ALP levels were highest in the VDDR group and
lowest in the HR group. ALP z-score was significantly lower in
the HR group (median: 3.6) than in the VDDR (median: 10.4)
and NR (median: 6.5) groups (p<0.001). A similar pattern was
observed for plasma PTH levels from highest to lowest in
VDDR, NR and HR (median values of 525, 237 and 98 pg/mL,
respectively). There were statistically significant differences
among the three groups (p<0.001). Serum calcium levels were
highest and serum phosphate levels were lowest in the HR
group (HR vs. VDDR and NR; medians: 9.4 vs. 8.9 and 
8.8 mg/dL for Ca, 2.5 vs. 2.9 and 2.9 mg/dL for phosphate,
respectively; p<0.05). Serum ALP levels of the individual
patients are shown in Figure 2. 
Discussion
In the present study, we described age- and sex-specific
serum ALP levels for ages 0 to 18 years. Serum ALP levels
were determined by a widely used colorimetric assay, with 
p-nitrophenyl phosphate as substrate and diethanolamine as
buffer. Serum ALP levels were also performed in patients 
with different types of rickets and were compared with the 
normative data. 
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Table 1. Mean serum ALP levels (U/L), -2SD, +2SD and square root transformed mean and SD values by age groups
Females (age groups) N -2SD Mean +2SD SQR-Mean SQR-SD
0-6 months 90 355 663 1037 25.5 3.3
6 -12 months 40 350 563 812 23.6 2.4
1 year 79 311 570 884 23.7 3.0
2-3 years 62 265 526 849 22.7 3.2
4-5 years 74 294 516 783 22.6 2.7
6-7 years 97 255 473 738 21.6 2.8
8-9 years 116 326 530 769 22.9 2.4
10-11 years 100 328 587 899 24.0 3.0
12-13 years 99 204 515 924 22.3 4.0
14-15 years 97 82 282 564 16.4 3.7
16-17 years 50 88 180 293 13.3 1.9
Males (age groups) N -2SD Mean +2SD SQR-Mean SQR-SD
0-6 months 86 297 746 1178 25.8 4.3
6 -12 months 36 299 611 998 24.4 3.6
1 year 61 327 664 1118 25.8 3.8
2-3 years 48 319 509 734 22.5 2.3
4-5 years 64 273 485 755 22.0 2.7
6-7 years 96 388 570 785 23.9 2.1
8-9 years 89 241 458 743 21.4 2.9
10-11 years 92 400 641 938 25.3 2.7
12-13 years 91 286 596 1000 24.3 3.7
14-15 years 108 164 559 1000 22.2 4.7
16-17 years 66 68 210 430 14.5 3.1
SQR: square root,  SD: standart deviation,   ALP: alkaline phosphataseIn healthy children, normal ALP levels showed a tetraphasic
pattern with highest levels in infancy and puberty and troughs
at mid-childhood and at the end of puberty. ALP levels were
similar during childhood in both sexes, but showed a dimorphic
pattern after the age of 10. Studies evaluating bone-specific
ALP levels demonstrate that 77% to 89% of the total ALP 
levels in children are of bone origin. The studies also indicate
that the increase in ALP in pubertal ages reflects the rapid
growth in puberty (3,4,5,7,13). Although, we did not check the
pubertal status of the children in this study, we can clearly see
the pubertal effect through the differences between boys and
girls during the pubertal ages. As a result of earlier onset, 
earlier growth spurt and earlier completion of puberty, most
girls in the 16-18 years age group reached ALP levels that were
compatible with the upper ranges of adult females. Boys
appear to reach the adult levels at later ages. These results 
confirm the previous data emphasizing that serum ALP levels
decline to the adult ranges after the age of 20 in boys and ages
17-18 years in girls (2,7). 
The mean ALP levels obtained in this study were similar to
the references, in which DEA is used as a buffer (6,7,8), but
higher than the values in the references using AMP as buffer
(2,14). Different normative data according to the methodology
necessitate development and use of z-scores when reporting
ALP levels in clinical studies and case reports. This important
issue is usually neglected. Thus, we also analyzed serum ALP
levels in 3 different types of rickets and, to our knowledge,
reported for the first time ALP z-scores for three different types
of rickets patients. The highest ALP levels were detected in
patients with VDDR and the lowest ones in HR patients; this
pattern was valid also for PTH levels. Serum calcium levels
were highest and, as expected, serum phosphate levels 
were lowest in HR patients. Furthermore, it is not possible to
compare our data with ALP levels reported in the literature
since there is no mention of buffers used for ALP 
measurement in rickets patients in most reports. We believe
that using ALP z-score in the follow-up of patients, instead of
using absolute ALP levels, would be more logical and free of
age- and sex-related physiological changes in ALP levels and
will give a better idea about the pathological process. 
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Figure 1. Serum ALP levels  according to age showing a tetraphasic
course from birth to adulthood
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Table 2. Serum calcium, phosphate, plasma parathyroid hormone
levels with serum ALP levels and ALP z-scores in patients with 
different types of rickets. Mean±SD values are given.
NR VDDR HR Reference
(n= 38) (n= 7) (n= 8) Ranges
Age (years) 1.5±1.3 4.7±4.4 9.2±5.5
Ca (mg/dL) 7.8±1.5& 8.8±0.8& 9.4±0.6& 8.4-10.5
P (mg/dL) 3.6±1.4& 3.3±0.9& 2.6±0.5& 3.8-6.5  
(1-3 years)
3.7-5.6   
(4-11 years)
2.9-5.4 
(12-15 years)
PTH (pg/mL) 323±218* 742±634* 120±71* 9-52
ALP (U/L) 2422±1098 3377±2052 1197±387
ALP z-score 7.1±3.8* 11.2±6.1* 4.2±1.6*
(range) (U)L) (2.3-18.0) (2.4-23.5) (2.1-7.4)
Number of  39 19 20
samples
*p<0.001, between three different group
&p<0.05, HR vs. VDDR and HR vs. NR
Ca: calcium,  P: phosphate,  PTH: parathormone,  ALP: alkaline phosphatase,
NR: nutritional rickets,  VDDR: vitamin-D dependent rickets, 
HR: hypophosphatemic ricketsAdditionally, not only normative upper limits of ALP, but also
the lower ones are of interest in clinical settings, especially in
hypophosphatasia patients. Hypophosphatasia is characterized
by low serum ALP activity (hypophosphatasemia) due to 
loss-of-function mutation within TNSALP, the gene that
encodes "tissue-nonspecific" ALP (15,16,17).  
We hope that this normative data for ALP levels will be 
useful in establishing the diagnosis and monitoring the 
treatment in patients with abnormal ALP levels. Determination
of z-scores for ALP will allow more precise assessment of
changes in ALP levels in rickets and other bone disorders.
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